Proto Labs (PRLB) is drawing renewed investor attention after its second quarter 2026 earnings, full year outlook update, and an employee stock offering were all announced on 31 July 2026.
See our latest analysis for Proto Labs.
The strong second quarter update and raised 2026 revenue growth outlook have arrived alongside a sharp shift in sentiment. Proto Labs has posted a 19.5% 1 month share price return and a 92.28% 1 year total shareholder return from a relatively low base, which suggests momentum has been building over both shorter and longer periods.
If Proto Labs has you rethinking where growth could come from next, it may be worth scanning other manufacturing focused automation plays using our screener for 37 robotics and automation stocks
After Proto Labs' strong run and higher 2026 revenue growth outlook, the stock now sits much closer to analyst targets. Does it make more sense to accept today’s price or wait and hope for a better entry later?
The most followed Proto Labs narrative pegs fair value at $88, which sits fractionally below the latest close of $88.91. That small gap puts the focus firmly on the earnings and margin story behind the target rather than a big valuation mismatch.
Ongoing investments in sales enablement, marketing, and optimization of fulfillment channels are improving customer experience and wallet share, evidenced by higher revenue per customer (+11% y/y) and increased cross-platform adoption (+44% y/y), which points to future top-line growth and improved earnings quality.
Want to see what kind of revenue and earnings profile has to sit behind that fair value for Proto Labs? The narrative leans on steady top line growth, rising margins and a premium profit multiple that pushes the valuation into territory usually reserved for higher growth peers. The key is how those ingredients are expected to stack together over the next few years.
Result: Fair Value of $88 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the Proto Labs narrative still faces real pressure from customer concentration in Aerospace & Defense, as well as ongoing weakness in European manufacturing that could hit revenue and margins.
Find out about the key risks to this Proto Labs narrative.
The mixed sentiment around Proto Labs, with both risks and rewards on the table, makes this a useful moment to move quickly and test the story against your own expectations using the 2 key rewards and 1 important warning sign.
If Proto Labs has sharpened your focus, do not stop here. Broaden your watchlist and stress test your thesis against other stocks with different risk and reward profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com